rs41291173

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4BS1BS2

The ENST00000606639.1(ENSG00000272180):​n.82+30766G>A variant causes a intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0141 in 532,846 control chromosomes in the GnomAD database, including 86 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.014 ( 25 hom., cov: 32)
Exomes 𝑓: 0.014 ( 61 hom. )

Consequence

ENSG00000272180
ENST00000606639.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 7.46

Publications

8 publications found
Variant links:
Genes affected
MIR217 (HGNC:31594): (microRNA 217) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
MIR217HG (HGNC:50537): (MIR217 host gene)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.18).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0141 (2152/152268) while in subpopulation AMR AF = 0.0275 (421/15310). AF 95% confidence interval is 0.0253. There are 25 homozygotes in GnomAd4. There are 985 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 25 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MIR217NR_029630.1 linkn.72C>T non_coding_transcript_exon_variant Exon 1 of 1
MIR217unassigned_transcript_353 n.1C>T non_coding_transcript_exon_variant Exon 1 of 1
MIR217HGNR_126406.1 linkn.209-19123C>T intron_variant Intron 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000272180ENST00000606639.1 linkn.82+30766G>A intron_variant Intron 1 of 6 1
MIR217ENST00000384817.3 linkn.72C>T non_coding_transcript_exon_variant Exon 1 of 1 6
MIR217HGENST00000446139.2 linkn.925-19123C>T intron_variant Intron 3 of 3 5

Frequencies

GnomAD3 genomes
AF:
0.0142
AC:
2153
AN:
152150
Hom.:
25
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00500
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0275
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00679
Gnomad MID
AF:
0.0223
Gnomad NFE
AF:
0.0201
Gnomad OTH
AF:
0.0230
GnomAD2 exomes
AF:
0.0135
AC:
3356
AN:
247852
AF XY:
0.0135
show subpopulations
Gnomad AFR exome
AF:
0.00420
Gnomad AMR exome
AF:
0.0162
Gnomad ASJ exome
AF:
0.00511
Gnomad EAS exome
AF:
0.000110
Gnomad FIN exome
AF:
0.00947
Gnomad NFE exome
AF:
0.0202
Gnomad OTH exome
AF:
0.0156
GnomAD4 exome
AF:
0.0140
AC:
5338
AN:
380578
Hom.:
61
Cov.:
0
AF XY:
0.0133
AC XY:
2888
AN XY:
216602
show subpopulations
African (AFR)
AF:
0.00392
AC:
41
AN:
10460
American (AMR)
AF:
0.0161
AC:
577
AN:
35938
Ashkenazi Jewish (ASJ)
AF:
0.00496
AC:
58
AN:
11700
East Asian (EAS)
AF:
0.00
AC:
0
AN:
13088
South Asian (SAS)
AF:
0.00420
AC:
278
AN:
66134
European-Finnish (FIN)
AF:
0.0101
AC:
327
AN:
32222
Middle Eastern (MID)
AF:
0.00847
AC:
24
AN:
2834
European-Non Finnish (NFE)
AF:
0.0198
AC:
3799
AN:
191540
Other (OTH)
AF:
0.0140
AC:
234
AN:
16662
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
251
502
752
1003
1254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0141
AC:
2152
AN:
152268
Hom.:
25
Cov.:
32
AF XY:
0.0132
AC XY:
985
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.00498
AC:
207
AN:
41556
American (AMR)
AF:
0.0275
AC:
421
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
17
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00291
AC:
14
AN:
4818
European-Finnish (FIN)
AF:
0.00679
AC:
72
AN:
10610
Middle Eastern (MID)
AF:
0.0205
AC:
6
AN:
292
European-Non Finnish (NFE)
AF:
0.0201
AC:
1366
AN:
68004
Other (OTH)
AF:
0.0227
AC:
48
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
108
216
325
433
541
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0137
Hom.:
4
Bravo
AF:
0.0146
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.18
CADD
Benign
19
DANN
Benign
0.87
PhyloP100
7.5

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41291173; hg19: chr2-56210140; API